These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20886663)

  • 1. High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynx.
    Figueiredo DL; Mamede RC; Spagnoli GC; Silva WA; Zago M; Neder L; Jungbluth AA; Saggioro FP
    Head Neck; 2011 May; 33(5):702-7. PubMed ID: 20886663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
    Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
    Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
    Figueiredo DL; Mamede RC; Proto-Siqueira R; Neder L; Silva WA; Zago MA
    Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.
    Pabst C; Zustin J; Jacobsen F; Luetkens T; Kröger N; Schilling G; Bokemeyer C; Sauter G; Atanackovic D; Marx A
    Exp Mol Pathol; 2010 Oct; 89(2):175-81. PubMed ID: 20621094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in squamous cell carcinoma of the penis.
    Hudolin T; Juretic A; Pasini J; Tomas D; Spagnoli GC; Heberer M; Dimanovski J; Kruslin B
    Urology; 2006 Jul; 68(1):205-7. PubMed ID: 16806422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
    Kienstra MA; Neel HB; Strome SE; Roche P
    Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer.
    Pastorcic-Grgic M; Sarcevic B; Dosen D; Juretic A; Spagnoli GC; Grgic M
    Head Neck; 2010 Sep; 32(9):1178-84. PubMed ID: 20029985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6).
    Cho HJ; Caballero OL; Gnjatic S; Andrade VC; Colleoni GW; Vettore AL; Outtz HH; Fortunato S; Altorki N; Ferrera CA; Chua R; Jungbluth AA; Chen YT; Old LJ; Simpson AJ
    Cancer Immun; 2006 Dec; 6():12. PubMed ID: 17137291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development.
    Gjerstorff MF; Kock K; Nielsen O; Ditzel HJ
    Hum Reprod; 2007 Apr; 22(4):953-60. PubMed ID: 17208940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we consider cancer/testis antigens NY-ESO-1, MAGE-A4 and MAGE-A1 as potential targets for immunotherapy in vulvar squamous cell carcinoma?
    Sznurkowski JJ; Zawrocki A; Karczewska J; Emerich J; Biernat W
    Histopathology; 2011 Feb; 58(3):481-3. PubMed ID: 21323970
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
    Dhodapkar MV; Osman K; Teruya-Feldstein J; Filippa D; Hedvat CV; Iversen K; Kolb D; Geller MD; Hassoun H; Kewalramani T; Comenzo RL; Coplan K; Chen YT; Jungbluth AA
    Cancer Immun; 2003 Jul; 3():9. PubMed ID: 12875607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MAGE-A1, MAGE-A3/4 and NY-ESO-1 cancer-testis antigens in fetal testis.
    Hudolin T; Kastelan Z; Derezić D; Basić-Jukić N; Cesare Spagnoli G; Juretić A; Jezek D
    Acta Dermatovenerol Croat; 2009; 17(2):103-7. PubMed ID: 19595265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
    Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
    Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
    Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue.
    Hudolin T; Juretic A; Spagnoli GC; Pasini J; Bandic D; Heberer M; Kosicek M; Cacic M
    Prostate; 2006 Jan; 66(1):13-8. PubMed ID: 16114059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.
    Sharma P; Shen Y; Wen S; Bajorin DF; Reuter VE; Old LJ; Jungbluth AA
    Clin Cancer Res; 2006 Sep; 12(18):5442-7. PubMed ID: 17000678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.